Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia.

Desiree KunadtMichael KramerClaudia DillHeidi AltmannLisa WagenführBrigitte MohrChristian ThiedeChristoph RölligJohannes ScheteligMartin BornhäuserMarkus SchaichFriedrich Stölzel

Published in: Biomarker research (2020)

This retrospective study was performed with patient samples registered within the prospective AML2003 trial (NCT00180102). Patients were enrolled between December 2003 and November 2009.

Keyphrases

acute myeloid leukemia
end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
allogeneic hematopoietic stem cell transplantation
prognostic factors
peritoneal dialysis
study protocol
phase ii
binding protein
long non coding rna
open label